S. Olofsson

Endocrinology, Diabetes and Metabolism · 2006–2008

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Olofsson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Marja-Riitta Taskinen

Papers from S. Olofsson's perspective

Ordered by how strongly the researchers S. Olofsson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. (Journal of Clinical Endocrinology and Metabolism)
  2. Global and societal implications of the diabetes epidemic (Nature)
  3. Molecular mediators of hepatic steatosis and liver injury. (Journal of Clinical Investigation)
  4. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. (Diabetes)
  5. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase (Nature Medicine)
  6. Diabetic dyslipidaemia: from basic research to clinical practice* (Diabetologia)
  7. Splanchnic lipolysis in human obesity. (Journal of Clinical Investigation)
  8. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (Nature)
  9. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex (Diabetologia)
  10. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. (Diabetes)

Their papers